What they were paid
MADRIGAL PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $94,000 | $409,397 | $0 | $0 | $503,397 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MADRIGAL PHARMACEUTICALS, INC. DEF 14A filed April 28, 2026, accession 0001308179-26-000352, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025MADRIGAL PHARMACEUTICALS pays directors a $50,000 cash retainer and $409,397 in equity.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the MADRIGAL PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Bill Sibold | Director | $0 |
| Daniel J. Brennan | Independent Director | $613,097 |
| Jacqualyn A. Fouse, Ph.D | Independent Director | $761,744 |
| James M. Daly | Independent Director | $477,022 |
| Paul A. Friedman, M.D | Director | $469,147 |
| Raymond Cheong, M.D., Ph.D | Independent Director | $494,897 |
| Rebecca Taub, M.D | Director | $0 |
| Richard S. Levy, M.D | Independent Director | $494,897 |
The full MADRIGAL PHARMACEUTICALS compensation record
free company briefThis page is one director within MADRIGAL PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat